BackBiondvax Pharmaceuticals Overview

Biondvax Pharmaceuticals Total Revenue

Revenue analysis for BVXV.

Quarterly Revenue

N/A

As of Jun 2023

Annual Revenue (TTM)

$2.02M
↓ 26.64% YoY

Trailing 12 months ending Jun 2023

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin